secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001493152-24-023119
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus stockholders approve amended 2021 stock plan at annual meeting
-----------------------------------------------------------------------

- Three Class III directors elected: Roger J. Pomerantz, Michael J. Newman, Jeffrey A. Meckler.
- Ratification of Haskell & White LLP as independent auditor for fiscal 2024 approved (3,805,215 FOR vs 469,553 AGAINST).
- Amendment to 2021 Stock Incentive Plan approved, increasing shares available and extending evergreen provision (1,881,194 FOR vs 501,555 AGAINST).
- Quorum of 4,277,437 shares (50.09% of outstanding) present at June 6, 2024 meeting.
- Plan amendment restatement effective June 6, 2024; full text filed as Exhibit 10.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224023119/0001493152-24-023119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224023119/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer